LDLR and atherosclerosis: Results presented in the current paper do not support a protective role for apoA-I mimetic L4F at a dose of 100 μg/day/mouse in weight gain, inflammation, insulin resistance, or atherosclerosis in a model of DIO (Ldlr-/- male mice fed HFHSC).